Vanqua Bio
Chicago, US · Founded 2019 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
RS
Rand SutherlandDirector
JS
James SullivanExecutive Officer, Director
JS
Jonathan SilversteinDirector
BD
Bernard DavitianDirector
UC
Uya ChuluunbaatarDirector
MA
Mona AshiyaDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$45MraisedJul 2024 · 12 investors · BiotechnologyRule 506(b)
▶$45MraisedJul 2024 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan SilversteinDirector
- Rand SutherlandDirector
- Bernard DavitianDirector
- Uya ChuluunbaatarDirector
- James SullivanExecutive Officer, Director
- Mona AshiyaDirector
- Offering amount
- $45M
- Amount sold
- $45M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$85MraisedSep 2021 · 11 investors · BiotechnologyRule 506(b)
▶$85MraisedSep 2021 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mona AshiyaDirector
- Viola MeehanExecutive Officer
- Bernard DavitianDirector
- Sara NayeemDirector
- James SullivanExecutive Officer, Director
- Jonathan SilversteinDirector
- Stephen SquintoDirector
- Offering amount
- $85M
- Amount sold
- $85M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$6MraisedOct 2019 · 1 investors · Other TechnologyRule 506(b)
▶$6MraisedOct 2019 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- JONATHAN SILVERSTEINExecutive Officer, Director
- JAMES SULLIVANExecutive Officer, Director
- MONA ASHIYADirector
- Offering amount
- $18M
- Amount sold
- $6M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.